Erratum: AGC1 Deficiency Causes Infantile Epilepsy, Abnormal Myelination, and Reduced N-Acetylaspartate (JIMD Reports, (2014) 14, 10.1007/8904_2013_287);AGC1 deficiency causes infantile epilepsy, abnormal myelination, and reduced N-acetylaspartate

JIMD Reports

Volumn 14, Issue , 2014, Pages 77-85

  Falk, Marni J ^a,g   Li, Dong ^a   Gai, Xiaowu ^b   McCormick, Elizabeth ^a   Place, Emily ^a,f   Lasorsa, Francesco M ^c   Otieno, Frederick G ^a   Hou, Cuiping ^a   Kim, Cecilia E ^a   Abdel Magid, Nada ^a   Vazquez, Lyam ^a   Mentch, Frank D ^a   Chiavacci, Rosetta ^a   Liang, Jinlong ^d   Liu, Xuanzhu ^d   Jiang, Hui ^d   Giannuzzi, Giulia ^e   Marsh, Eric D ^a   Yiran, Guo ^a   Tian, Lifeng ^a   Palmieri, Ferdinando ^c,e   Hakonarson, Hakon ^a   more..

^a CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^b LOYOLA UNIVERSITY CHICAGO   (United States)

^c CNR   (Italy)

^d BGI SHENZHEN   (China)

^e UNIVERSITY OF BARI   (Italy)

^f HARVARD MEDICAL SCHOOL   (United States)

^g Harvard Medical School ^*  (United States)

Author keywords

Epileptic encephalopathy; Intractable epilepsy; Ketogenic diet; Mitochondrial disease; Whole exome sequencing

Indexed keywords

EID: 85060290951     PISSN: 21928304     EISSN: 21928312     Source Type: Book Series    
DOI: 10.1007/8904_2014_314     Document Type: Erratum

References (21)

1. Calvo SE, Compton AG, Hershman SG, et al (2012) Molecular diagnosis of infantile mitochondrial disease with targeted next-generation sequencing. Sci Trans Med 4(118): 118ra110
2. Falk MJ, Pierce EA, Consugar M et al (2012) Mitochondrial disease genetic diagnostics: optimized whole-exome analysis for all MitoCarta nuclear genes and the mitochondrial genome. Discov Med 14(79):389–399
3. Fiermonte G, Paradies E, Todisco S, Marobbio CM, Palmieri F (2009) A novel member of solute carrier family 25 (SLC25A42) is a transporter of coenzyme A and adenosine 3',5'-diphosphate in human mitochondria. J Biol Chem 284(27):18152–18159
4. Haas RH, Parikh S, Falk MJ et al (2007) Mitochondrial disease: a practical approach for primary care physicians. Pediatrics 120 (6):1326–1333
5. Haas RH, Parikh S et al (2008) The in-depth evaluation of suspected mitochondrial disease: Mitochondrial Medicine Society's Committee on diagnosis. Mol Genet Metab 94(1):16–37
6. Iijima M, Jalil A, Begum L et al (2001) Pathogenesis of adult-onset type II citrullinemia caused by deficiency of citrin, a mitochondrial solute carrier protein: tissue and subcellular localization of citrin. Adv Enzyme Regul 41:325–342
7. Lasorsa FM, Pinton P, Palmieri L, Fiermonte G, Rizzuto R, Palmieri F (2003) Recombinant expression of the Ca(2+)-sensitive aspartate/ glutamate carrier increases mitochondrial ATP production in agonist-stimulated Chinese hamster ovary cells. J Biol Chem 278 (40):38686–38692
8. McCormick E, Place E, Falk MJ (2013) Molecular genetic testing for mitochondrial disease: from one generation to the next. Neuro-therapeutics: J Am Soc Exper NeuroTherap 10(2):251–261
9. Molinari F, Raas-Rothschild A, Rio M et al (2005) Impaired mitochondrial glutamate transport in autosomal recessive neonatal myoclonic epilepsy. Am J Hum Genet 76(2):334–339
10. Molinari F, Kaminska A, Fiermonte G et al (2009) Mutations in the mitochondrial glutamate carrier SLC25A22 in neonatal epileptic encephalopathy with suppression bursts. Clin Genet 76 (2):188–194
11. Palmieri F (2004) The mitochondrial transporter family (SLC25): physiological and pathological implications. Pflugers Archiv: Eur J Physiol 447(5):689–709
12. Palmieri F (2013) The mitochondrial transporter family SLC25: identification, properties and physiopathology. Mol Aspects Med 34(2–3):465–484
13. Palmieri F, Indiveri C, Bisaccia F, Iacobazzi V (1995) Mitochondrial metabolite carrier proteins: purification, reconstitution, and transport studies. Methods Enzymol 260:349–369
14. Palmieri L, Pardo B, Lasorsa FM et al (2001) Citrin and aralar1 are Ca (2+)-stimulated aspartate/glutamate transporters in mitochondria. EMBO J 20(18):5060–5069
15. Pierri CL, Palmieri F, De Grassi A (2014) Single-nucleotide evolution quantifies the importance of each site along the structure of mitochondrial carriers. Cell Mol Life Sci 71(2):349–364. doi:10.1007/s00018-013-1389-y
16. Poduri A, Heinzen EL, Chitsazzadeh V et al (2013) SLC25A22 is a novel gene for migrating partial seizures in infancy. Ann Neurol. doi:10.1002/ana.23998(17 Oct 2013)
17. Ramos M, Pardo B, Llorente-Folch I, Saheki T, Del Arco A, Satrustegui J (2011) Deficiency of the mitochondrial transporter of aspartate/glutamate aralar/AGC1 causes hypomyelination and neuronal defects unrelated to myelin deficits in mouse brain. J Neurosci Res 89(12):2008–2017
18. Saheki T, Kobayashi K (2002) Mitochondrial aspartate glutamate carrier (citrin) deficiency as the cause of adult-onset type II citrullinemia (CTLN2) and idiopathic neonatal hepatitis (NICCD). J Hum Genet 47(7):333–341
19. Wibom R, Lasorsa FM, Tohonen V et al (2009) AGC1 deficiency associated with global cerebral hypomyelination. N Engl J Med 361(5):489–495
20. Wolf NI, van der Knaap MS (2009) AGC1 deficiency and cerebral hypomyelination. The New England journal of medicine 361(20): 1997–1998; author reply 1998
21. Wong LJ (2010) Molecular genetics of mitochondrial disorders. Dev Disabil Res Rev 16(2):154–162